Crossmark

Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan

Crossref DOI link: https://doi.org/10.1186/s13023-021-01990-3

Published Online: 2021-08-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iijima, Naoki

Yamauchi, Junji

Yagishita, Naoko

Araya, Natsumi

Aratani, Satoko

Tanabe, Kenichiro

Sato, Tomoo

Takata, Ayako

Yamano, Yoshihisa http://orcid.org/0000-0001-7527-0345
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (21ek0109529)

Ministry of Health, Labour and Welfare (19FC1007)
License Information

Text and Data Mining valid from 2021-08-09

Version of Record valid from 2021-08-09
More Information

Article History

Received: 1 June 2021

Accepted: 29 July 2021

First Online: 9 August 2021

Declarations

:

: This study was approved by the St. Marianna University School of Medicine Bioethics Committee (Approval ID No. 2044). All participants in this study provided written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below